Brief: RxSight Says Anticipates FY 2024 Revenue Of $128 Mln-$135 Mln, Reflecting Growth Of About 44%-52% Over 2023
Jan 7 (Reuters) - Rxsight Inc RXST.O :
* RXSIGHT, INC. ANNOUNCES PRELIMINARY UNAUDITED FOURTH
QUARTER AND
FULL-YEAR 2023 FINANCIAL AND OPERATIONAL RESULTS AND 2024
GUIDANCE
* ANTICIPATES FULL-YEAR 2024 REVENUE OF $128.0 MILLION TO
$135.0
MILLION, REFLECTING GROWTH OF APPROXIMATELY 44% TO 52% OVER 2023
* CURRENTLY ESTIMATES FULL-YEAR 2024 GROSS PROFIT MARGIN TO
BE IN
65% - 67% RANGE
Source text for Eikon: ID:nGNXcckTq9
Further company coverage: RXST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RxSight
See all newsUS RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
Eye care company Alcon raises margin outlook, shares jump (updated)
RxSight, Inc. reports results for the quarter ended June 30 - Earnings Summary
RxSight Q2 adjusted loss beats estimates; withdraws 2026 guidance
Brief: Rxsight Inc Q2 Operating Expenses USD 39.7 Million